SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054604
Filing Date
2024-05-07
Accepted
2024-05-07 16:30:43
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20240331.htm   iXBRL 10-Q 1965594
2 EX-31.1 adpt-ex31_1.htm EX-31.1 16771
3 EX-31.2 adpt-ex31_2.htm EX-31.2 16765
4 EX-32.1 adpt-ex32_1.htm EX-32.1 10145
5 EX-32.2 adpt-ex32_2.htm EX-32.2 11316
  Complete submission text file 0000950170-24-054604.txt   8296555

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20240331.xsd EX-101.SCH 1137204
77 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20240331_htm.xml XML 1520251
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 24922500
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)